• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»TROP2 antibody drug conjugate

Akari Therapeutics Plc advances AKTX-101 as RNA splicing ADC targets TROP2 resistance in oncology

By Soujanya Ravi on April 20, 2026   Pharma & Biotech  

Akari Therapeutics Plc advances AKTX-101 as RNA splicing ADC targets TROP2 resistance in oncology

Discover how AKTX-101 could redefine TROP2 ADC resistance strategies in oncology. Read the full analysis now.

Recent Posts

  • Why CytoDyn Inc.’s leronlimab data could reshape TNBC immunotherapy strategies
  • Akari Therapeutics Plc advances AKTX-101 as RNA splicing ADC targets TROP2 resistance in oncology
  • Why Oragenics, Inc.’ ONP-002 Phase IIa progress could redefine concussion treatment pathways
  • What Orion Corporation’s FDA orphan designation for ODM-212 means for mesothelioma treatment innovation
  • Can Nektar’s 52-week REZOLVE-AA update strengthen the case for rezpegaldesleukin in alopecia areata?
  • Can Whitehawk Therapeutics turn preclinical ADC depth into a real oncology pipeline advantage?
  • Medtronic backs Pulnovo Medical in $100m round to expand PADN in pulmonary hypertension
  • Why CStone Pharmaceuticals’ CS5007 may be the most important asset in its AACR 2026 antibody-drug conjugate update
  • Orthogon Therapeutics adds $11m for BK virus drug, targeting one of transplant medicine’s toughest gaps
  • LEO Pharma wins China approval for Enstilar, but can topical psoriasis leadership scale in the world’s biggest patient market?
  • Obodence at WCO 2026: Samsung Bioepis sharpens the clinical case for SB16 adoption
  • Khondrion moves sonlicromanol into Phase 3, but can KHENERFIN finally crack mitochondrial disease?
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes